SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-21-000102
Filing Date
2021-03-26
Accepted
2021-03-26 08:32:45
Documents
17
Period of Report
2021-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20210326.htm   iXBRL 8-K 40213
2 EX-1.1 ex11032621.htm EX-1.1 284653
3 EX-5.1 ex5132621.htm EX-5.1 18839
9 image1a.jpg GRAPHIC 1668
  Complete submission text file 0001570562-21-000102.txt   556925

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210326.xsd EX-101.SCH 2430
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20210326_cal.xml EX-101.CAL 718
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20210326_def.xml EX-101.DEF 1655
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210326_lab.xml EX-101.LAB 24975
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210326_pre.xml EX-101.PRE 13195
10 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210326_htm.xml XML 11034
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 21774825
SIC: 2834 Pharmaceutical Preparations